| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC25A24 SLC2A10 CACNA1E SLC36A1 SLC16A6 MRS2 SLC15A4 ATRAID COX4I1 SLC22A2 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC35F1 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC2A1 SLC44A3 SLC5A1 ITPR1 SLC5A4 | 3.26e-12 | 1180 | 81 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC25A24 SLC2A10 CACNA1E SLC36A1 SLC16A6 MRS2 SLC15A4 ATRAID COX4I1 SLC22A2 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC35F1 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC2A1 SLC44A3 SLC5A1 ITPR1 SLC5A4 | 2.22e-11 | 1289 | 81 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC25A24 SLC2A10 CACNA1E SLC36A1 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 1.35e-10 | 758 | 81 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC2A10 CACNA1E SLC36A1 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 4.48e-10 | 627 | 81 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC2A10 CACNA1E SLC36A1 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 1.07e-09 | 664 | 81 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC2A10 SLC36A1 SLC15A4 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC5A1 SLC5A4 | 1.27e-09 | 119 | 81 | 9 | GO:0015294 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC2A10 CACNA1E SLC36A1 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 2.17e-09 | 793 | 81 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A24 SLC2A10 SLC36A1 SLC15A4 SLC9A7 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 SLC5A4 | 2.56e-09 | 296 | 81 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC2A10 SLC36A1 SLC15A4 COX4I1 SLC9A7 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 SLC5A4 | 3.09e-09 | 301 | 81 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A24 SLC2A10 SLC36A1 SLC15A4 COX4I1 SLC22A2 SLC9A7 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 SLC5A4 | 6.89e-09 | 477 | 81 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | SLC2A10 SLC36A1 SLC15A4 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC5A1 SLC5A4 | 9.85e-09 | 150 | 81 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A24 SLC2A10 SLC36A1 SLC16A6 SLC15A4 SLC22A2 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 2.74e-08 | 293 | 81 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | SLC2A10 SLC36A1 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF SLC9A6 SLC5A4 | 6.98e-08 | 188 | 81 | 9 | GO:0015078 |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 7.29e-08 | 27 | 81 | 5 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.07e-07 | 29 | 81 | 5 | GO:0051119 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC36A1 SLC16A6 SLC15A4 SLC22A2 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 1.59e-07 | 207 | 81 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC36A1 SLC16A6 SLC15A4 SLC22A2 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 1.66e-07 | 208 | 81 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 5.74e-07 | 17 | 81 | 4 | GO:0005402 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 7.33e-07 | 42 | 81 | 5 | GO:0015144 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.09e-06 | 83 | 81 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E MRS2 SLC9A7 TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 2.71e-06 | 465 | 81 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.98e-06 | 25 | 81 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.98e-06 | 25 | 81 | 4 | GO:0015295 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.98e-06 | 25 | 81 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | dehydroascorbic acid transmembrane transporter activity | 3.55e-06 | 8 | 81 | 3 | GO:0033300 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.10e-06 | 171 | 81 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.02e-05 | 71 | 81 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.34e-05 | 36 | 81 | 4 | GO:0090482 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.95e-05 | 81 | 81 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.82e-05 | 105 | 81 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 9.65e-05 | 59 | 81 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.10e-04 | 61 | 81 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 1.61e-04 | 5 | 81 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.18e-04 | 29 | 81 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 2.41e-04 | 6 | 81 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 3.37e-04 | 7 | 81 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 3.37e-04 | 7 | 81 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.51e-04 | 34 | 81 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 3.83e-04 | 35 | 81 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 4.48e-04 | 8 | 81 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | signal recognition particle binding | 4.48e-04 | 8 | 81 | 2 | GO:0005047 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 5.74e-04 | 9 | 81 | 2 | GO:0015180 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 6.13e-04 | 41 | 81 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 7.16e-04 | 10 | 81 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | hormone binding | 8.19e-04 | 103 | 81 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 1.23e-03 | 13 | 81 | 2 | GO:0015173 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 1.43e-03 | 14 | 81 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.43e-03 | 14 | 81 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 1.45e-03 | 55 | 81 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.88e-03 | 16 | 81 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 1.88e-03 | 16 | 81 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 2.12e-03 | 17 | 81 | 2 | GO:0052816 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 2.66e-03 | 19 | 81 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 2.94e-03 | 20 | 81 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.26e-03 | 73 | 81 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 3.56e-03 | 22 | 81 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 3.89e-03 | 23 | 81 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 4.23e-03 | 24 | 81 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 5.34e-03 | 27 | 81 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 5.34e-03 | 27 | 81 | 2 | GO:0047617 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.49e-03 | 526 | 81 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 5.74e-03 | 28 | 81 | 2 | GO:0016289 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.86e-03 | 90 | 81 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.32e-03 | 196 | 81 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | spectrin binding | 8.38e-03 | 34 | 81 | 2 | GO:0030507 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC2A10 CACNA1E THBS1 SLC36A1 SLC15A4 SLC22A2 SLC9A7 TRPV6 SLC1A1 SLC9A6 SLC2A1 SLC5A1 | 6.30e-11 | 230 | 78 | 12 | GO:0098739 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | THBS1 SLC36A1 SLC16A6 SLC15A4 SLC22A2 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 7.23e-10 | 167 | 78 | 10 | GO:1903825 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC2A10 CACNA1E SLC36A1 ANK1 ANK2 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 7.79e-10 | 1017 | 78 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC2A10 CACNA1E SLC36A1 ANK2 MRS2 SLC15A4 COX4I1 CYSLTR1 SLC22A2 SLC9A7 UMOD SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 1.14e-09 | 1157 | 78 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC2A10 CACNA1E SLC36A1 ANK2 MRS2 SLC15A4 COX4I1 CYSLTR1 SLC22A2 SLC9A7 UMOD SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 4.26e-09 | 1374 | 78 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC2A10 CACNA1E SLC36A1 ANK1 ANK2 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 7.26e-09 | 922 | 78 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A24 SLC2A10 THBS1 SLC36A1 SLC16A6 SLC15A4 SLC22A2 UMOD SLC36A3 PLA2G6 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 7.27e-09 | 515 | 78 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | THBS1 SLC36A1 SLC15A4 SLC22A2 SLC36A3 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 1.10e-08 | 163 | 78 | 9 | GO:1905039 |
| GeneOntologyBiologicalProcess | proton transmembrane transport | SLC2A10 SLC36A1 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF SLC9A6 SLC5A4 | 1.59e-08 | 170 | 78 | 9 | GO:1902600 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | THBS1 SLC36A1 SLC16A6 SLC15A4 SLC22A2 UMOD SLC36A3 PLA2G6 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 4.31e-08 | 410 | 78 | 12 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | THBS1 SLC36A1 SLC16A6 SLC15A4 SLC22A2 UMOD SLC36A3 PLA2G6 SLC5A8 SLC1A1 SLC23A1 SLC2A1 | 4.55e-08 | 412 | 78 | 12 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC2A10 CACNA1E SLC36A1 ANK2 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 6.42e-08 | 942 | 78 | 17 | GO:0098655 |
| GeneOntologyBiologicalProcess | import into cell | SORT1 SLC2A10 CACNA1E THBS1 SLC36A1 ANK2 PPT1 SLC15A4 TM9SF4 INPPL1 SLC22A2 SLC9A7 PLA2G6 TRPV6 SLC1A1 SLC9A6 SLC2A1 SLC5A1 | 7.49e-08 | 1074 | 78 | 18 | GO:0098657 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC2A10 CACNA1E SLC36A1 ANK2 MRS2 SLC15A4 COX4I1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC1A1 SLC23A1 ANO3 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 1.31e-07 | 1115 | 78 | 18 | GO:0034220 |
| GeneOntologyBiologicalProcess | D-glucose import across plasma membrane | 5.17e-07 | 5 | 78 | 3 | GO:0098708 | |
| GeneOntologyBiologicalProcess | carbohydrate import across plasma membrane | 1.03e-06 | 6 | 78 | 3 | GO:0098704 | |
| GeneOntologyBiologicalProcess | hexose import across plasma membrane | 1.03e-06 | 6 | 78 | 3 | GO:0140271 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 1.91e-06 | 154 | 78 | 7 | GO:0015749 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 3.41e-06 | 168 | 78 | 7 | GO:0034219 | |
| GeneOntologyBiologicalProcess | dehydroascorbic acid transport | 4.30e-06 | 9 | 78 | 3 | GO:0070837 | |
| GeneOntologyBiologicalProcess | carbohydrate transport | 6.67e-06 | 186 | 78 | 7 | GO:0008643 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1E ANK1 ANK2 PPT1 OBP2A TBC1D1 TM9SF4 SLC9A7 UMOD PLA2G6 TRPV6 C1QTNF3 SLC1A1 SLC9A6 ADIPOR2 ITPR1 | 1.44e-05 | 1249 | 78 | 16 | GO:0048878 |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC2A10 CACNA1E ANK2 PPT1 TBC1D1 TM9SF4 SLC9A7 UMOD PLA2G6 C1QTNF3 IDE SLC1A1 SLC9A6 ITPR1 | 1.64e-05 | 981 | 78 | 14 | GO:0019725 |
| GeneOntologyBiologicalProcess | organic cation transport | 1.84e-05 | 145 | 78 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.97e-05 | 87 | 78 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1E ANK2 MRS2 CYSLTR1 SLC9A7 UMOD TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC5A1 ITPR1 SLC5A4 | 2.04e-05 | 1000 | 78 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 2.07e-05 | 148 | 78 | 6 | GO:1904659 | |
| GeneOntologyBiologicalProcess | vascular transport | 2.08e-05 | 88 | 78 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 2.32e-05 | 151 | 78 | 6 | GO:0008645 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 5.59e-05 | 108 | 78 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | vitamin transport | 5.99e-05 | 56 | 78 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 7.61e-05 | 22 | 78 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.18e-05 | 275 | 78 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 9.22e-05 | 120 | 78 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1E ANK2 PPT1 TBC1D1 TM9SF4 SLC9A7 UMOD PLA2G6 C1QTNF3 SLC1A1 SLC9A6 ITPR1 | 9.41e-05 | 866 | 78 | 12 | GO:0055082 |
| GeneOntologyBiologicalProcess | circulatory system process | SLC2A10 CACNA1E NPR2 ANK2 CYSLTR1 SLC22A2 UMOD PLA2G6 SLC1A1 SLC2A1 SLC5A1 | 9.42e-05 | 733 | 78 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 1.08e-04 | 65 | 78 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 1.43e-04 | 27 | 78 | 3 | GO:0098719 | |
| GeneOntologyBiologicalProcess | regulation of protein exit from endoplasmic reticulum | 1.43e-04 | 27 | 78 | 3 | GO:0070861 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 1.44e-04 | 132 | 78 | 5 | GO:0015908 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 1.56e-04 | 213 | 78 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.03e-04 | 142 | 78 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.03e-04 | 142 | 78 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | galactose transmembrane transport | 2.10e-04 | 6 | 78 | 2 | GO:0015757 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | CACNA1E TBC1D1 TM9SF4 DERL3 DERL2 UMOD PLA2G6 C1QTNF3 SLC1A1 ITPR1 | 2.21e-04 | 674 | 78 | 10 | GO:0070201 |
| GeneOntologyBiologicalProcess | regulation of protein transport | 2.59e-04 | 560 | 78 | 9 | GO:0051223 | |
| GeneOntologyBiologicalProcess | response to luteinizing hormone | 2.93e-04 | 7 | 78 | 2 | GO:0034699 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 3.16e-04 | 705 | 78 | 10 | GO:0055080 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 3.23e-04 | 344 | 78 | 7 | GO:0003018 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 3.32e-04 | 87 | 78 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 3.61e-04 | 717 | 78 | 10 | GO:0050801 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 3.90e-04 | 8 | 78 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 3.90e-04 | 8 | 78 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 3.99e-04 | 38 | 78 | 3 | GO:0070633 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 4.46e-04 | 94 | 78 | 4 | GO:0051453 | |
| GeneOntologyBiologicalProcess | metanephros development | 4.64e-04 | 95 | 78 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | negative regulation of retrograde protein transport, ER to cytosol | 5.00e-04 | 9 | 78 | 2 | GO:1904153 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 5.85e-04 | 101 | 78 | 4 | GO:0030641 | |
| GeneOntologyBiologicalProcess | negative regulation of protein exit from endoplasmic reticulum | 6.23e-04 | 10 | 78 | 2 | GO:0070862 | |
| GeneOntologyBiologicalProcess | choline transport | 6.23e-04 | 10 | 78 | 2 | GO:0015871 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | 7.13e-04 | 644 | 78 | 9 | GO:0090407 | |
| GeneOntologyBiologicalProcess | proline transmembrane transport | 7.60e-04 | 11 | 78 | 2 | GO:0035524 | |
| GeneOntologyBiologicalProcess | urate transport | 7.60e-04 | 11 | 78 | 2 | GO:0015747 | |
| GeneOntologyBiologicalProcess | L-alanine transport | 7.60e-04 | 11 | 78 | 2 | GO:0015808 | |
| GeneOntologyBiologicalProcess | amino acid transport | 8.66e-04 | 195 | 78 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | response to endoplasmic reticulum stress | 8.82e-04 | 295 | 78 | 6 | GO:0034976 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SORT1 CYP1B1 THBS1 NPR2 OBP2A INPPL1 DERL3 DERL2 UMOD IDE SLC1A1 SLC2A1 ITPR1 | 9.08e-04 | 1272 | 78 | 13 | GO:1901698 |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 9.09e-04 | 12 | 78 | 2 | GO:0015911 | |
| GeneOntologyBiologicalProcess | epithelial fluid transport | 9.09e-04 | 12 | 78 | 2 | GO:0042045 | |
| GeneOntologyBiologicalProcess | protein exit from endoplasmic reticulum | 9.51e-04 | 51 | 78 | 3 | GO:0032527 | |
| GeneOntologyBiologicalProcess | regulation of pH | 1.12e-03 | 120 | 78 | 4 | GO:0006885 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.16e-03 | 208 | 78 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of retrograde protein transport, ER to cytosol | 1.25e-03 | 14 | 78 | 2 | GO:1904152 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.34e-03 | 126 | 78 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.38e-03 | 58 | 78 | 3 | GO:0089718 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.42e-03 | 128 | 78 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | regulation of cGMP-mediated signaling | 1.44e-03 | 15 | 78 | 2 | GO:0010752 | |
| GeneOntologyBiologicalProcess | azole transmembrane transport | 1.44e-03 | 15 | 78 | 2 | GO:0045117 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 9 signaling pathway | 1.44e-03 | 15 | 78 | 2 | GO:0034163 | |
| GeneOntologyBiologicalProcess | glycine transport | 1.44e-03 | 15 | 78 | 2 | GO:0015816 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.52e-03 | 60 | 78 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 1.64e-03 | 16 | 78 | 2 | GO:0019852 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.68e-03 | 134 | 78 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 1.77e-03 | 229 | 78 | 5 | GO:0006643 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 1.77e-03 | 338 | 78 | 6 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 1.79e-03 | 339 | 78 | 6 | GO:0033500 | |
| GeneOntologyBiologicalProcess | response to hormone | SORT1 CYP1B1 THBS1 NPR2 OBP2A INPPL1 RXFP2 IDE MSI1 SLC2A1 ADIPOR2 | 1.81e-03 | 1042 | 78 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.84e-03 | 64 | 78 | 3 | GO:0042908 | |
| GeneOntologyCellularComponent | basal plasma membrane | 9.24e-06 | 354 | 81 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.56e-05 | 378 | 81 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC36A1 ANK2 SLC22A2 UMOD SLC5A8 SLC1A1 SLC23A1 SLC2A1 SLC5A1 | 1.11e-04 | 487 | 81 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.43e-04 | 320 | 81 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | apical part of cell | SLC36A1 ANK2 SLC22A2 UMOD SLC5A8 SLC1A1 SLC23A1 SLC2A1 SLC5A1 | 4.69e-04 | 592 | 81 | 9 | GO:0045177 |
| GeneOntologyCellularComponent | early endosome | 5.48e-04 | 481 | 81 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | transport vesicle | 8.99e-04 | 519 | 81 | 8 | GO:0030133 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 9.69e-04 | 293 | 81 | 6 | GO:0030658 | |
| Domain | NA_SOLUT_SYMP_1 | 1.17e-05 | 11 | 79 | 3 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 1.56e-05 | 12 | 79 | 3 | PS00457 | |
| Domain | SSF | 1.56e-05 | 12 | 79 | 3 | PF00474 | |
| Domain | Na/solute_symporter | 1.56e-05 | 12 | 79 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.56e-05 | 12 | 79 | 3 | PS50283 | |
| Domain | MFS_dom | 2.21e-05 | 134 | 79 | 6 | IPR020846 | |
| Domain | SUGAR_TRANSPORT_2 | 4.75e-05 | 17 | 79 | 3 | PS00217 | |
| Domain | DER1 | 5.29e-05 | 3 | 79 | 2 | IPR007599 | |
| Domain | Na/H_exchanger_6 | 5.29e-05 | 3 | 79 | 2 | IPR002090 | |
| Domain | EGF_3 | 6.13e-05 | 235 | 79 | 7 | PS50026 | |
| Domain | EGF-like_dom | 8.81e-05 | 249 | 79 | 7 | IPR000742 | |
| Domain | MFS | 9.45e-05 | 108 | 79 | 5 | PS50850 | |
| Domain | EGF_1 | 1.02e-04 | 255 | 79 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.18e-04 | 261 | 79 | 7 | IPR013032 | |
| Domain | EGF_2 | 1.30e-04 | 265 | 79 | 7 | PS01186 | |
| Domain | SUGAR_TRANSPORT_1 | 1.38e-04 | 24 | 79 | 3 | PS00216 | |
| Domain | TSP_3 | 1.75e-04 | 5 | 79 | 2 | PF02412 | |
| Domain | TSP3 | 1.75e-04 | 5 | 79 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.75e-04 | 5 | 79 | 2 | PS51236 | |
| Domain | - | 1.75e-04 | 5 | 79 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.75e-04 | 5 | 79 | 2 | IPR008859 | |
| Domain | TSP_C | 1.75e-04 | 5 | 79 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.75e-04 | 5 | 79 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 1.75e-04 | 5 | 79 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.75e-04 | 5 | 79 | 2 | IPR028974 | |
| Domain | Sugar_transporter_CS | 3.31e-04 | 32 | 79 | 3 | IPR005829 | |
| Domain | MFS_sugar_transport-like | 4.70e-04 | 36 | 79 | 3 | IPR005828 | |
| Domain | Sugar_tr | 4.70e-04 | 36 | 79 | 3 | PF00083 | |
| Domain | EGF | 4.81e-04 | 235 | 79 | 6 | SM00181 | |
| Domain | Na/solute_symporter_CS | 4.87e-04 | 8 | 79 | 2 | IPR018212 | |
| Domain | NaH_exchanger | 6.24e-04 | 9 | 79 | 2 | IPR004709 | |
| Domain | ZU5 | 6.24e-04 | 9 | 79 | 2 | SM00218 | |
| Domain | ZU5 | 7.78e-04 | 10 | 79 | 2 | PS51145 | |
| Domain | Cation/H_exchanger_CPA1 | 9.48e-04 | 11 | 79 | 2 | IPR018422 | |
| Domain | EGF_3 | 1.13e-03 | 12 | 79 | 2 | PF12947 | |
| Domain | EGF_dom | 1.13e-03 | 12 | 79 | 2 | IPR024731 | |
| Domain | ZU5 | 1.13e-03 | 12 | 79 | 2 | PF00791 | |
| Domain | ZU5_dom | 1.13e-03 | 12 | 79 | 2 | IPR000906 | |
| Domain | Na_H_Exchanger | 1.56e-03 | 14 | 79 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 1.56e-03 | 14 | 79 | 2 | IPR006153 | |
| Domain | Sugar/inositol_transpt | 1.56e-03 | 14 | 79 | 2 | IPR003663 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 79 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.89e-03 | 124 | 79 | 4 | IPR001881 | |
| Domain | Aa_trans | 2.31e-03 | 17 | 79 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 2.31e-03 | 17 | 79 | 2 | IPR013057 | |
| Domain | TSP_1 | 2.41e-03 | 63 | 79 | 3 | PF00090 | |
| Domain | TSP1 | 2.63e-03 | 65 | 79 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.63e-03 | 65 | 79 | 3 | IPR000884 | |
| Domain | TSP1 | 2.63e-03 | 65 | 79 | 3 | PS50092 | |
| Domain | 6-PGluconate_DH_C-like | 2.88e-03 | 19 | 79 | 2 | IPR008927 | |
| Domain | TSPN | 4.22e-03 | 23 | 79 | 2 | SM00210 | |
| Domain | TM4_1 | 5.38e-03 | 26 | 79 | 2 | PS00421 | |
| Domain | - | 5.74e-03 | 169 | 79 | 4 | 3.40.50.720 | |
| Domain | DEATH | 5.79e-03 | 27 | 79 | 2 | SM00005 | |
| Domain | EGF_CA | 5.79e-03 | 86 | 79 | 3 | PF07645 | |
| Domain | VWC | 6.22e-03 | 28 | 79 | 2 | PF00093 | |
| Domain | NAD(P)-bd_dom | 6.23e-03 | 173 | 79 | 4 | IPR016040 | |
| Domain | Tetraspanin | 8.07e-03 | 32 | 79 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 8.07e-03 | 32 | 79 | 2 | IPR008952 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A10 SLC36A1 SLC15A4 SLC22A2 SLC9A7 SLC5A8 SLC1A1 SLC9A6 SLC2A1 SLC44A3 SLC5A1 SLC5A4 | 2.78e-10 | 238 | 60 | 12 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A10 SLC36A1 SLC15A4 SLC22A2 SLC9A7 SLC5A8 SLC1A1 SLC9A6 SLC2A1 SLC44A3 SLC5A1 SLC5A4 | 4.68e-10 | 249 | 60 | 12 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A10 SLC36A1 MRS2 SLC15A4 DERL3 SLC22A2 DERL2 SLC9A7 TRPV6 SLC5A8 SLC1A1 ANO3 SLC9A6 SLC2A1 SLC44A3 SLC5A1 SLC5A4 | 1.92e-09 | 681 | 60 | 17 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC2A10 SLC36A1 MRS2 SLC15A4 DERL3 SLC22A2 DERL2 SLC9A7 TRPV6 SLC5A8 SLC1A1 ANO3 SLC9A6 SLC2A1 SLC44A3 SLC5A1 SLC5A4 | 6.19e-09 | 736 | 60 | 17 | M27287 |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.10e-06 | 19 | 60 | 4 | MM14718 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.68e-06 | 21 | 60 | 4 | M27058 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 4.16e-06 | 57 | 60 | 5 | M39812 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.29e-06 | 108 | 60 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.64e-06 | 109 | 60 | 6 | MM15074 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 9.63e-06 | 177 | 60 | 7 | M27476 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 6.21e-05 | 99 | 60 | 5 | M27474 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 9.39e-05 | 108 | 60 | 5 | M17034 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.46e-04 | 72 | 60 | 4 | MM14631 | |
| Pathway | WP_NRF2_PATHWAY | 3.27e-04 | 141 | 60 | 5 | M39454 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 3.57e-04 | 314 | 60 | 7 | M39428 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 4.91e-04 | 8 | 60 | 2 | M27091 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 6.29e-04 | 9 | 60 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 6.29e-04 | 9 | 60 | 2 | MM15079 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 6.29e-04 | 9 | 60 | 2 | MM14769 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER | 7.48e-04 | 42 | 60 | 3 | M39740 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.56e-04 | 11 | 60 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.14e-03 | 12 | 60 | 2 | MM1526 | |
| Pubmed | 4.86e-06 | 105 | 81 | 5 | 30280653 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 5.36e-06 | 2 | 81 | 2 | 16181801 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17620335 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20364249 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 5.36e-06 | 2 | 81 | 2 | 23660684 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11279194 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 39122122 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34425286 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 5.36e-06 | 2 | 81 | 2 | 22930728 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 5.36e-06 | 2 | 81 | 2 | 8126073 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38339060 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34925309 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33372257 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21762961 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9694593 | ||
| Pubmed | Cholinergic augmentation of insulin release requires ankyrin-B. | 5.36e-06 | 2 | 81 | 2 | 20234002 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 14722080 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12213711 | ||
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 5.36e-06 | 2 | 81 | 2 | 12358136 | |
| Pubmed | Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. | 5.36e-06 | 2 | 81 | 2 | 8471772 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 5.36e-06 | 2 | 81 | 2 | 1712771 | |
| Pubmed | Structure and mechanism of the SGLT family of glucose transporters. | 5.36e-06 | 2 | 81 | 2 | 34880492 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 25837797 | ||
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 5.36e-06 | 2 | 81 | 2 | 10027393 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18303017 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33981184 | ||
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 5.36e-06 | 2 | 81 | 2 | 18594557 | |
| Pubmed | A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. | 5.36e-06 | 2 | 81 | 2 | 24699711 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 5.36e-06 | 2 | 81 | 2 | 15037577 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30928339 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 5.36e-06 | 2 | 81 | 2 | 33759165 | |
| Pubmed | 6.79e-06 | 52 | 81 | 4 | 26590417 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26241338 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 9373030 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 1.60e-05 | 3 | 81 | 2 | 18787106 | |
| Pubmed | Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency. | 1.60e-05 | 3 | 81 | 2 | 26168218 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18032585 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19818485 | ||
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 1.60e-05 | 3 | 81 | 2 | 17638877 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 30939949 | ||
| Pubmed | Akt substrate TBC1D1 regulates GLUT1 expression through the mTOR pathway in 3T3-L1 adipocytes. | 1.60e-05 | 3 | 81 | 2 | 18215134 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12527750 | ||
| Pubmed | Organization and expression of the SLC36 cluster of amino acid transporter genes. | 1.60e-05 | 3 | 81 | 2 | 15058382 | |
| Pubmed | A cluster of proton/amino acid transporter genes in the human and mouse genomes. | 1.60e-05 | 3 | 81 | 2 | 12809675 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21177872 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 1.60e-05 | 3 | 81 | 2 | 17442977 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19004835 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 37747441 | ||
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 1.60e-05 | 3 | 81 | 2 | 8463250 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 1.60e-05 | 3 | 81 | 2 | 12482844 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.60e-05 | 3 | 81 | 2 | 26168731 | |
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 1.60e-05 | 3 | 81 | 2 | 33410423 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 1.60e-05 | 3 | 81 | 2 | 16598380 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27513329 | ||
| Pubmed | Characterization and modulation of glucose uptake in a human blood-brain barrier model. | 1.60e-05 | 3 | 81 | 2 | 23975336 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15347840 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25976449 | ||
| Pubmed | Localization of Glucose Transporter 10 to Hair Cells' Cuticular Plate in the Mouse Inner Ear. | 1.60e-05 | 3 | 81 | 2 | 30013986 | |
| Pubmed | Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium. | 1.60e-05 | 3 | 81 | 2 | 11749115 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31092423 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 1.60e-05 | 3 | 81 | 2 | 1459996 | |
| Pubmed | Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity. | 1.60e-05 | 3 | 81 | 2 | 24088896 | |
| Pubmed | Post-oral appetite stimulation by sugars and nonmetabolizable sugar analogs. | 1.60e-05 | 3 | 81 | 2 | 23926132 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 1.60e-05 | 3 | 81 | 2 | 8400410 | |
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 1.60e-05 | 3 | 81 | 2 | 34289389 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 16597699 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 33069367 | ||
| Pubmed | New loci associated with kidney function and chronic kidney disease. | 1.76e-05 | 66 | 81 | 4 | 20383146 | |
| Pubmed | 1.82e-05 | 22 | 81 | 3 | 20965718 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SLC25A24 CYP1B1 SEC24D THBS2 ACLY COX4I1 PYCR1 ATP5MF CTIF CMTM7 SLC9A6 SLC2A1 ITPR1 | 2.94e-05 | 1451 | 81 | 13 | 30550785 |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 19147503 | ||
| Pubmed | Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes. | 3.20e-05 | 4 | 81 | 2 | 32617672 | |
| Pubmed | Derlin-3 Is Required for Changes in ERAD Complex Formation under ER Stress. | 3.20e-05 | 4 | 81 | 2 | 32858914 | |
| Pubmed | A membrane protein required for dislocation of misfolded proteins from the ER. | 3.20e-05 | 4 | 81 | 2 | 15215855 | |
| Pubmed | Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions. | 3.20e-05 | 4 | 81 | 2 | 21171650 | |
| Pubmed | WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1. | 3.20e-05 | 4 | 81 | 2 | 31816312 | |
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 3.20e-05 | 4 | 81 | 2 | 6338048 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 18089612 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 12909644 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11980922 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 10900205 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20847111 | ||
| Pubmed | 4.16e-05 | 82 | 81 | 4 | 20301334 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 30622267 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 15522866 | ||
| Pubmed | Derlin-dependent accumulation of integral membrane proteins at cell surfaces. | 5.33e-05 | 5 | 81 | 2 | 19509052 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16449189 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 37170065 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 16292983 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 23806329 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 18668520 | ||
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 7.99e-05 | 6 | 81 | 2 | 1716634 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 26572137 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.68e-05 | 38 | 81 | 3 | 30786075 | |
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 9.68e-05 | 38 | 81 | 3 | 16263699 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 2968981 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 1.12e-04 | 7 | 81 | 2 | 7495297 | |
| Cytoband | 5q33.1 | 9.72e-04 | 26 | 81 | 2 | 5q33.1 | |
| Cytoband | 22q12.3 | 1.57e-03 | 33 | 81 | 2 | 22q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 1.95e-03 | 139 | 81 | 3 | chr5p13 | |
| GeneFamily | Solute carriers | SLC25A24 SLC2A10 SLC36A1 SLC16A6 SLC15A4 SLC22A2 SLC9A7 SLC36A3 SLC5A8 SLC35F1 SLC1A1 SLC23A1 SLC9A6 SLC2A1 SLC44A3 SLC5A1 SLC5A4 | 9.42e-16 | 395 | 54 | 17 | 752 |
| GeneFamily | Rhomboid family | 7.79e-04 | 14 | 54 | 2 | 926 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC2A10 THBS1 SLC36A1 TSPAN11 TM9SF4 ENTPD6 DOLK DERL2 PPIL2 CTIF SLC9A6 SLC2A1 UNC50 | 1.63e-07 | 681 | 81 | 13 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SLC2A10 THBS1 SLC36A1 TSPAN11 TM9SF4 ENTPD6 DOLK DERL2 PPIL2 CTIF SLC9A6 SLC2A1 UNC50 | 2.34e-07 | 703 | 81 | 13 | MM1055 |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_DN | 3.69e-05 | 200 | 81 | 6 | M5112 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_UP | 3.69e-05 | 200 | 81 | 6 | M4851 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_100 | 1.07e-05 | 76 | 81 | 5 | gudmap_developingKidney_e15.5_Proximal Tubules_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_200 | 1.97e-05 | 42 | 81 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_200 | 2.27e-05 | 149 | 81 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | GREB1L APH1B TSPAN11 SLC16A6 EHHADH SLC22A2 UMOD MFSD6L SLC5A8 SLC1A1 SLC23A1 SLC5A1 | 4.02e-05 | 784 | 81 | 12 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | 1.18e-04 | 389 | 81 | 8 | gudmap_developingKidney_e15.5_Proximal Tubules_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.67e-04 | 409 | 81 | 8 | GSM605840_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 1.70e-04 | 410 | 81 | 8 | GSM854297_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.75e-04 | 412 | 81 | 8 | GSM605843_500 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500 | 2.13e-04 | 424 | 81 | 8 | gudmap_kidney_adult_RenalCortexMixed_Std_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.49e-04 | 230 | 81 | 6 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#3_top-relative-expression-ranked_100 | 2.69e-04 | 33 | 81 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_100_k3 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-1 | 2.77e-04 | 332 | 81 | 7 | GSM538230_500 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | 3.03e-04 | 337 | 81 | 7 | GSM538228_500 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-08 | 196 | 81 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-08 | 196 | 81 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-07 | 168 | 81 | 6 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 187 | 81 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 192 | 81 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 193 | 81 | 6 | 3038ed3e53d3367136fac5c9773cd5b7414f49d3 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 193 | 81 | 6 | c5925b3b5d19098e3987789d68a493d7fd548ac9 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 193 | 81 | 6 | 6905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-06 | 193 | 81 | 6 | f73630725f093c646bdaf178c39505c04a16e2c6 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-06 | 129 | 81 | 5 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 162 | 81 | 5 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 162 | 81 | 5 | f12c08d0d4406f9560ecfc3bc2ff38c3bc58f184 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 165 | 81 | 5 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 165 | 81 | 5 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.28e-05 | 165 | 81 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 166 | 81 | 5 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 167 | 81 | 5 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.39e-05 | 168 | 81 | 5 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.39e-05 | 168 | 81 | 5 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 81 | 5 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 169 | 81 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 170 | 81 | 5 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.74e-05 | 176 | 81 | 5 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-05 | 178 | 81 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 180 | 81 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 180 | 81 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 181 | 81 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 181 | 81 | 5 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 182 | 81 | 5 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 81 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 81 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.16e-05 | 184 | 81 | 5 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 184 | 81 | 5 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.16e-05 | 184 | 81 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-05 | 185 | 81 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.21e-05 | 185 | 81 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 186 | 81 | 5 | fa5f602f01de5beec529d9f5208172b2914a952d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.33e-05 | 187 | 81 | 5 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 187 | 81 | 5 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 188 | 81 | 5 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 189 | 81 | 5 | a174f5757a53a68a753111a204efc1bb6da80d8b | |
| ToppCell | 3'-Airway_Nasal_SMG|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 189 | 81 | 5 | bb2b626645e9f060f0d99d05d1ea651fd8bc4945 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.45e-05 | 189 | 81 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 189 | 81 | 5 | 24741fe93438c1031fc5caa8837ef82d8d23f099 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 189 | 81 | 5 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 189 | 81 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 190 | 81 | 5 | a124e1c12af70161b9ead5d677afa660610444ee | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 190 | 81 | 5 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-05 | 191 | 81 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 81 | 5 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-05 | 191 | 81 | 5 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-05 | 191 | 81 | 5 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 81 | 5 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-05 | 191 | 81 | 5 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 2.58e-05 | 191 | 81 | 5 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 191 | 81 | 5 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.65e-05 | 192 | 81 | 5 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.65e-05 | 192 | 81 | 5 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.65e-05 | 192 | 81 | 5 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 192 | 81 | 5 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 192 | 81 | 5 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 192 | 81 | 5 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 192 | 81 | 5 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.65e-05 | 192 | 81 | 5 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 193 | 81 | 5 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.71e-05 | 193 | 81 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-05 | 193 | 81 | 5 | 30abf991ac17c18679ab7d633e7549c0ce841920 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-05 | 193 | 81 | 5 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 194 | 81 | 5 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 194 | 81 | 5 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 194 | 81 | 5 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 194 | 81 | 5 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 195 | 81 | 5 | d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 195 | 81 | 5 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 195 | 81 | 5 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.85e-05 | 195 | 81 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 196 | 81 | 5 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 197 | 81 | 5 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 2.99e-05 | 197 | 81 | 5 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 3.07e-05 | 198 | 81 | 5 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.22e-05 | 200 | 81 | 5 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-05 | 200 | 81 | 5 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.22e-05 | 200 | 81 | 5 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.22e-05 | 200 | 81 | 5 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.22e-05 | 200 | 81 | 5 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.32e-05 | 130 | 81 | 4 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| Drug | sodium | SLC2A10 SLC36A1 ANK2 PPT1 SLC9A7 SLC36A3 ATP5MF TRPV6 SLC5A8 SLC1A1 SLC23A1 SLC9A6 SLC2A1 SLC5A1 SLC5A4 | 1.04e-06 | 944 | 81 | 15 | CID000000923 |
| Drug | GF109203X | CACNA1E THBS1 INPPL1 PLA2G6 PLCXD3 SLC1A1 SLC5A1 ITPR1 SLC5A4 | 3.45e-06 | 341 | 81 | 9 | CID000002396 |
| Drug | alpha-(methylamino)isobutyric acid | 4.35e-06 | 31 | 81 | 4 | CID000075725 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HG-U133A | 6.83e-06 | 198 | 81 | 7 | 1907_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.83e-06 | 198 | 81 | 7 | 3785_DN | |
| Drug | AC1NSPXR | 7.01e-06 | 11 | 81 | 3 | CID005313815 | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 7.06e-06 | 199 | 81 | 7 | 366_DN | |
| Drug | hydride | CYP1B1 CACNA1E NPR2 SLC36A1 EHHADH COX4I1 SLC9A7 PYCR1 SLC36A3 ATP5MF SLC1A1 SLC9A6 SLC5A1 | 7.41e-06 | 835 | 81 | 13 | CID000000783 |
| Drug | XeC compound | 1.25e-05 | 84 | 81 | 5 | CID000005701 | |
| Drug | Betaine | 2.07e-05 | 157 | 81 | 6 | ctd:D001622 | |
| Drug | EIPA | 2.27e-05 | 95 | 81 | 5 | CID000001795 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.39e-05 | 161 | 81 | 6 | 3556_DN | |
| Drug | indoxyl-beta-D-glucoside | 2.85e-05 | 17 | 81 | 3 | CID000092769 | |
| Drug | IDD594 | 3.02e-05 | 50 | 81 | 4 | CID004369325 | |
| Drug | gentamicin C | 3.74e-05 | 3 | 81 | 2 | ctd:C100093 | |
| Drug | potassium | PHAF1 CACNA1E NPR2 PPT1 SLC9A7 SLC36A3 ATP5MF TRPV6 PLCXD3 SLC1A1 SLC9A6 SLC5A1 ITPR1 | 5.33e-05 | 1008 | 81 | 13 | CID000000813 |
| Drug | Probenecid | 5.83e-05 | 59 | 81 | 4 | ctd:D011339 | |
| Drug | AC1NBU2S | 6.17e-05 | 117 | 81 | 5 | CID004473765 | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A | 6.39e-05 | 192 | 81 | 6 | 4830_DN | |
| Drug | IAA-94 | 6.65e-05 | 61 | 81 | 4 | CID000003667 | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 6.76e-05 | 194 | 81 | 6 | 4110_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 4281_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 3728_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 5800_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4757_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4222_UP | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 5859_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 6867_DN | |
| Drug | 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate | 7.47e-05 | 4 | 81 | 2 | ctd:C006014 | |
| Drug | lercanidipine | 7.55e-05 | 63 | 81 | 4 | CID000065866 | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 4007_UP | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; HL60; HG-U133A | 7.57e-05 | 198 | 81 | 6 | 1572_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 6248_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 81 | 6 | 3520_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; PC3; HT_HG-U133A | 8.00e-05 | 200 | 81 | 6 | 6613_UP | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 8.00e-05 | 200 | 81 | 6 | 251_UP | |
| Drug | T2 D | 9.11e-05 | 127 | 81 | 5 | CID004369452 | |
| Drug | bumetanide | 1.02e-04 | 209 | 81 | 6 | CID000002471 | |
| Drug | 4 alpha-phorbol 12,13-didecanoate | 1.14e-04 | 70 | 81 | 4 | CID000452543 | |
| Drug | amicetose | 1.24e-04 | 5 | 81 | 2 | CID000193083 | |
| Drug | 3-O-methyl-D-glucose | 1.27e-04 | 72 | 81 | 4 | CID000008973 | |
| Disease | Obesity | 2.29e-04 | 205 | 79 | 5 | C0028754 | |
| Disease | creatinine measurement, glomerular filtration rate | 2.80e-04 | 117 | 79 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | ascorbic acid 3-sulfate measurement | 6.31e-04 | 14 | 79 | 2 | EFO_0800173 | |
| Disease | Diabetic Angiopathies | 8.29e-04 | 16 | 79 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 8.29e-04 | 16 | 79 | 2 | C0025945 | |
| Disease | nevus count | 1.05e-03 | 18 | 79 | 2 | EFO_0004632 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.17e-03 | 171 | 79 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | HbA1c measurement, response to sulfonylurea | 1.44e-03 | 21 | 79 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | Nephritis, Tubulointerstitial | 1.44e-03 | 21 | 79 | 2 | C0041349 | |
| Disease | Dystonia | 1.61e-03 | 86 | 79 | 3 | C0013421 | |
| Disease | Nephritis, Interstitial | 1.88e-03 | 24 | 79 | 2 | C0027707 | |
| Disease | Malignant neoplasm of breast | 2.28e-03 | 1074 | 79 | 9 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLGFGIMSGVFSFVN | 121 | Q8WW43 | |
| GFFSVSARAVTGMAG | 221 | P51689 | |
| GFITFLCEVFGTMRS | 476 | O43310 | |
| VFALLGMQLFGGRFN | 616 | Q15878 | |
| TGFLVSFMVDARGGS | 911 | P16157 | |
| LGTGITFIMFGVSSF | 461 | P20594 | |
| NYAGRGTTGMVARFI | 231 | Q58WW2 | |
| RGRTADFVFMFLFGG | 91 | Q96Q80 | |
| LFDNGGTVFFAIFMA | 466 | Q9BYT9 | |
| IFGRVVGGFDVLTAM | 396 | Q13356 | |
| VSNLQEFRFMIGGGC | 366 | Q86V24 | |
| FGFLGMQSLVFGAQD | 456 | Q86XR2 | |
| MSVGFIGAGQLAFAL | 1 | P32322 | |
| VRMGGSFRGAFSNSE | 446 | Q7Z628 | |
| SGFLVSFMVDARGGA | 966 | Q01484 | |
| EKMGFGSISRVFARG | 381 | Q674X7 | |
| FFERFGIVVAATGMA | 106 | Q9UPQ8 | |
| FLMSFVGNCGTFTRG | 2376 | Q14643 | |
| GMIGSFSVGLFVNRF | 76 | P11166 | |
| LMVFVSAFSFGFGPV | 416 | O95528 | |
| VVVGNCFGFVGNRML | 471 | Q08426 | |
| LGSFVGGFVVMRFSL | 506 | Q8IWD5 | |
| GGAAQIFFLTLMGVA | 96 | Q8NG97 | |
| TFSLSLFGLMGVAFG | 346 | Q9HD23 | |
| GTIQILFGIMTFSFG | 51 | Q9H3V2 | |
| AVNFLTGMGGFLQAV | 581 | Q32M88 | |
| ALGGGNLEATFTFMR | 56 | Q9NY56 | |
| RSLGVALGVFMTIGF | 16 | Q96RP7 | |
| GMFNNAGVGAARFLI | 1571 | Q9C091 | |
| RGFGFVTFMDQAGVD | 61 | O43347 | |
| AMGFSQGGQFLRAVA | 111 | P50897 | |
| NFFDVMTGRFGAPVS | 146 | Q9BXJ4 | |
| LMRDFSPSGIFGAFQ | 31 | P56134 | |
| VRTCGFDFGGNIIMF | 96 | Q13347 | |
| AVVINGSMYIFGGFS | 586 | Q5VV63 | |
| LLRFGFSAMFGFGGR | 341 | Q49MI3 | |
| FSAMFGFGGRTLALA | 346 | Q49MI3 | |
| VFIMGYSVVAGAAGR | 46 | Q8N4M1 | |
| ASFRVVSGGRSMAFG | 121 | Q16678 | |
| GARGFMFFIINVDLT | 366 | P14735 | |
| RGRTADFVFMFLFGG | 91 | Q9GZP9 | |
| KTVVGGAMFFIGFTA | 101 | P13073 | |
| SAIMGLFFFFSGVGS | 486 | Q8N697 | |
| VNVGFFIGSMSIGYI | 156 | O15244 | |
| FRTMVNVLGDAFGTG | 446 | P43005 | |
| MFRSRSIEVFGQFNG | 61 | P02748 | |
| MAIAEVFGRIGAGFV | 336 | O15403 | |
| FGLGGRFLFASVMAD | 306 | Q99523 | |
| SIGIFLGIFSGSFAM | 291 | Q92581 | |
| FYGIMFDAGSTGTRV | 101 | O75354 | |
| KGAVGVSFMFNGTSF | 541 | O15357 | |
| AFITCFGNLFVIGMR | 426 | Q8WXD0 | |
| AMLKTNRGTIGGFFL | 46 | Q9NY91 | |
| FANSIGALVGLMAGF | 436 | Q8N695 | |
| FFNGRLAGLQRGAMS | 1896 | Q9NT68 | |
| MQFFGRLVNTFSGVT | 1 | O60733 | |
| GSTFCFGLQRMIFEV | 381 | Q9BSU1 | |
| STGFRATDFFGGILM | 696 | O94855 | |
| FFGTAIFTFEGVGMV | 256 | Q495N2 | |
| ALNGIFVLGRSMGFI | 1056 | P53396 | |
| GSFSLLMFFGILGAT | 196 | Q6UW56 | |
| NQSGLVAGAIFGFMA | 136 | Q96FZ5 | |
| SMISVVGFFGNGFVL | 31 | Q9Y271 | |
| GMIGLFGAFFSGIQL | 251 | Q5T1Q4 | |
| TMNFTGQLGAGIRYF | 81 | Q63HM9 | |
| TGQFLTFREINGMTG | 241 | A0AVT1 | |
| MFSGFNVFRVGISFV | 1 | Q9P2K2 | |
| TIGFGFVLDMGFFET | 96 | Q53HI1 | |
| GRLGLFVFSQEMVFF | 1146 | P07996 | |
| GESSQGRFSVQMFRF | 541 | P07911 | |
| FMFMGVFGGFSAGRL | 386 | Q92544 | |
| FFGTAIFSFEGIGMV | 261 | Q7Z2H8 | |
| RNLFVLGFSMFFGLT | 456 | Q9UHI7 | |
| RVFQGFFTGRGRSCM | 466 | O95235 | |
| GFVARVFDMIFLQGT | 981 | Q86TI0 | |
| DIFRMGVTRFFGQTI | 446 | Q9H1D0 | |
| FAGVLVMVTGFLGFG | 66 | A1L157 | |
| AGGRLGLFVFSQEMV | 1146 | P35442 | |
| IFLGIFSGSFTMGAV | 326 | Q96T83 | |
| AMFSTNRGTVGGFFL | 46 | P13866 | |
| TNMGIIAGVAFGIAF | 211 | P41732 | |
| IGTFERFISGSMAGA | 286 | Q6NUK1 |